Mission to Sell the World’s Last Cigarette Before the 22nd Century
(We think a better headline would have been "Mission to be the World's Last Cigarette Brand Standing," but we didn't write it..)
COMPASS Pathways (CMPS) Announces Up to $285 Million Private Placement
Transaction led by healthcare specialist investors, TCGX and Aisling Capital
$125 million financing upfront with up to...
Our 10 Top Turnaround Situations Under $5.00.
Can These Stocks Double in Value, and Still be 70% off Their Recent High?
Read More...
Bridging the Immunity Gap: An In-Depth Conversation with GeoVax’s (GOVX) CEO, David Dodd
In an era of rapid scientific development, the pharmaceutical industry constantly evolves to meet new challenges and seize emerging opportunities. GeoVax, a...
Tsunami of Business Headed Pressure Bio’s (PBIO) Way?
We think there is a potential Tsunami of business headed towards Pressure Bio over then next 3-5 years. And well beyond....
Report: Is Psycheceutical BioScience (BWVI) One of the Most Important Companies in the Psychedelic...
Initiating Coverage on Psycheceutical BioScience (BWVI).
"Imagine Applying a Psychedelic Topically, Receiving the Benefits...
Is Ultra-Shear’s™ Nano-THC the Most Powerful and Fast-Acting THC in the World?
We Think it is!
Webinar to discuss effectiveness.
The Company does not make CBD...
Billionaire, Point 72’s Steve Cohen, Continues to Support Psychedelic Research.
Cohen Psychedelic Research & Health Initiative
Cohen Foundation Awards $5 Million for MDMA Therapy Approval
Millions...
Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial...
Completion of Enrollment Remains on Track for Q1, 2024
"While we recently had fireworks, we could be looking at...
Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...
Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests...
Latest article
Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.
119% Gain Post Split
Nine Page Summary Report on GeoVax (GOVX)
This is a great long-term story. We’re telling you.
(March 2024) When we finished writing our earlier...
GeoVax (GOVX) Provides First Half 2024 Business Update.
Award of BARDA Project NextGen contract represents a significant milestone event;
Total value...
